Indications and uses
helps prevent sunburn if used as directed with other sun protection measures (See directions) decreases the risk of cancer and early skin aging causes by the sun.
helps prevent sunburn if used as directed with other sun protection measures (See directions) decreases the risk of cancer and early skin aging causes by the sun.
Apply liberally to face and neck 15 minutes before sun exposure. Reapply: At least every 2 hours Immediately after towel drying After 80 minutes of swimming or sweating Children under 6 month - ask a doctor Sun Protection Measures: Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other su...
BENZOPHENONE-3 4%
HOMOSALATE 10%
ETHYL SALICYLATE 5%
BUTYLBENZOYLMETHANE 15%
OCTOCRYLENE 2%
BENZOPHENONE-3 .....................................................Sunscreen
HOMOSALATE .....................................................Sunscreen
ETHYL SALICYLATE .................................................Sunscreen
BUTYLBENZOYLMETHANE ........................................Sunscreen
OCTOCRYLENE ........................................................Sunscreen
For external use only.
avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.
if rash occurs.
If swallowed, get medical help or contact a poison control center immediately.
This cosmetic product should be used only for the purpose it was intended and according to its instructions. Do not ingest.
Children under 6 month - ask a doctor
Sun Protection Measures:
Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
Isododecane, Dimethicone, Bis-Isobutyl PPG-20 Crosspolymer, Dicapryl Ether, Tocopheryl Acetate (Vitamin E), Astaxanthin, Plukenetia Volubilis Seed Oil, Tocopherol.
*Contains Oxybenzone.
Protect the product in this container from excessive heat and direct sun.
845-501-0127
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 1 | |
| HOMOSALATE | ACTIVE INGREDIENT | V06SV4M95S | 1 | |
| OCTISALATE | ACTIVE INGREDIENT | 4X49Y0596W | 1 | |
| OCTOCRYLENE | ACTIVE INGREDIENT | 5A68WGF6WM | 1 | |
| OXYBENZONE | ACTIVE INGREDIENT | 95OOS7VE0Y | 1 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 1 | |
| HOMOSALATE | ACTIVE MOIETY | V06SV4M95S | 1 | |
| OCTISALATE | ACTIVE MOIETY | 4X49Y0596W | 1 | |
| OCTOCRYLENE | ACTIVE MOIETY | 5A68WGF6WM | 1 | |
| OXYBENZONE | ACTIVE MOIETY | 95OOS7VE0Y | 1 | |
| .ALPHA.-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| ASTAXANTHIN | INACTIVE INGREDIENT | 8XPW32PR7I | 1 | |
| BIS-ISOBUTYLENE PPG-20 | INACTIVE INGREDIENT | 5R9772B6IK | 1 | |
| DIDECYL ETHER | INACTIVE INGREDIENT | DA81HI310Z | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| ISODODECANE | INACTIVE INGREDIENT | A8289P68Y2 | 1 | |
| PLUKENETIA VOLUBILIS SEED OIL | INACTIVE INGREDIENT | 8ED72Z8J1Z | 1 | |
| TOCOPHEROL | INACTIVE INGREDIENT | R0ZB2556P8 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69939-051 | 69939-051-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ISODODECANE | A8289P68Y2 | IACT |
| DIMETHICONE | 92RU3N3Y1O | IACT |
| BIS-ISOBUTYLENE PPG-20 | 5R9772B6IK | IACT |
| DIDECYL ETHER | DA81HI310Z | IACT |
| .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | IACT |
| ASTAXANTHIN | 8XPW32PR7I | IACT |
| PLUKENETIA VOLUBILIS SEED OIL | 8ED72Z8J1Z | IACT |
| TOCOPHEROL | R0ZB2556P8 | IACT |
| OXYBENZONE | 95OOS7VE0Y | ACTIB |
| HOMOSALATE | V06SV4M95S | ACTIB |
| OCTISALATE | 4X49Y0596W | ACTIB |
| AVOBENZONE | G63QQF2NOX | ACTIB |
| OCTOCRYLENE | 5A68WGF6WM | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| TOCOPHEROL | TOCOPHEROL | R0ZB2556P8 | CAPSULE, COATED / ORAL | 0.25 mg | ||
| TOCOPHEROL | TOCOPHEROL | R0ZB2556P8 | CREAM / TOPICAL | NA | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| TOCOPHEROL | TOCOPHEROL | R0ZB2556P8 | TABLET / ORAL | 0.08 mg | ||
| TOCOPHEROL | TOCOPHEROL | R0ZB2556P8 | INJECTION, EMULSION / INTRAVENOUS | 0.02 %w/v | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| TOCOPHEROL | TOCOPHEROL | R0ZB2556P8 | CAPSULE / ORAL | NA | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 90b472dc-510e-f81d-e053-2a95a90a85c0 | cc4ad37b-eceb-49e5-8f51-74b4ec0877de | 2019-08-22 | Warnings | 90b472dc-510e-f81d-e053-2a95a90a85c0 cc4ad37b-eceb-49e5-8f51-74b4ec0877de |
Adverse event summaries are temporarily unavailable. Other product information remains available.